We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Fetal Monitoring Available for Obstetricians on the Go

By HospiMedica International staff writers
Posted on 19 Dec 2012
A new fetal monitor provides clinicians access to maternal and fetal surveillance information via an iPad or iPhone interface, driving efficiency at the point of care (POC). More...


The Cerner FetaLink+ solution provides a graphical display of the relationship between fetal heart rates and contraction data, allowing clinicians to assess the status of patients by displaying the fetal and maternal waveforms and the relationship between them; clinicians can thus more easily analyze changes in waveform patterns over time. Additionally, clinicians can temporarily or permanently hide or display any waveforms, thus analyzing each waveform independently or in conjunction with waveforms of choice to support decision-making.

Clinicians can also quickly view annotations and the annotation summary on the fetal strip, offering a quick way to review a chronological order of vital signs and annotation entries. The summary also serves as a navigation tool for viewing a historical waveform at the correlating time of entry. The Cerner FetaLink+ solution also integrates with the Cerner PowerChart Touch and the Cerner PowerChart Maternity solution, thus populating the lifetime electronic health records (EHRs) for the mother and the baby, gathering data even before a baby is born.

Further benefits include near real-time access to critical information about a woman’s pregnancy and the health of her baby, improving patient safety and helping clinicians make informed decisions; creating mobile access to fetal and maternal waveform data and key pregnancy related data such as estimated due date (EDD), estimated gestational age (EGA), cervical exam status, and gravida para; and allowing clinicians to compare historical pregnancy data that can be used to evaluate the health of subsequent pregnancies. The Cerner FetaLink+, PowerChart Touch, and PowerChart Maternity solutions are products of Cerner (Kansas City, MO, USA), and have been approved by the US Food and Drug Administration (FDA).

“We recognize that OBGYN providers are constantly on the go and need immediate access to key maternal and fetal information from any location,” said Patrizia Smouse, managing director of the Cerner Women’s Health Team. “FetaLink+ is a native application for use on iPads and iPhones. It will allow OB providers visibility to what’s going on within the hospital by displaying maternal and fetal monitoring data and additional clinical data.”

Related Links:

Cerner


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Exam Table
PF400
Portable Jaundice Management Device
Nymphaea
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.